NCT06320730View on ClinicalTrials.gov

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

3,790

Participants

Timeline

Start Date

August 25, 2020

Primary Completion Date

August 29, 2020

Study Completion Date

March 1, 2021

Conditions
Acute Kidney InjuryHyperglycemiaHypoglycemiaEnd Stage Liver Disease
Interventions
OTHER

Observational study, records of blood glucose level after reperfusion

Analyzes blood glucose level after reperfusion by dividing it into two groups: those with blood glucose levels between 110 and 180 and those with blood glucose levels below 110 or above 180.

Trial Locations (1)

05500

Jun-Gol Song, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT06320730 - Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation | Biotech Hunter | Biotech Hunter